Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Akzo Nobel N.V. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $11.21B | $10.73B - $11.76B | $1.79B | $4.55 | 15 |
| Dec 2029 | $10.99B | $10.52B - $11.53B | $1.75B | $5.373 | 15 |
| Dec 2028 | $10.55B | $10.10B - $11.07B | $1.68B | $4.62 | 14 |
| Dec 2027 | $10.36B | $9.87B - $10.88B | $1.65B | $4.314 | 16 |
| Dec 2026 | $10.10B | $9.71B - $10.59B | $1.61B | $3.879 | 17 |
| Dec 2025 | $10.22B | $10.12B - $10.34B | $1.63B | $3.633 | 19 |
| Dec 2024 | $10.64B | $10.64B - $10.71B | $1.69B | $4.033 | 18 |
| Dec 2023 | $11.76B | $11.42B - $11.96B | $1.57B | $3.465 | 9 |
| Dec 2022 | $11.58B | $11.15B - $12.10B | $1.55B | $2.811 | 3 |
| Dec 2021 | $10.91B | $10.50B - $11.40B | $1.46B | $4.109 | 4 |
| Dec 2020 | $10.44B | $10.05B - $10.91B | $1.40B | $3.697 | 4 |
| Dec 2019 | $10.48B | $10.09B - $10.95B | $1.40B | $3.003 | 3 |